{
    "clinical_study": {
        "@rank": "31774", 
        "arm_group": {
            "arm_group_label": "ALS patients", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "ALS is a severe progressive neurodegenerative disease characterized by degeneration motor\n      neurons leading to death in 3 to 5 years. Gradually in time, the patient deprived of all\n      motor skills as well as the possibility of communication written and oral developing a state\n      close Locked In Syndrome (LIS). The main objective is to establish the feasibility of\n      brain-computer interface using the pathological condition, with dependent disabled subjects\n      as a means of communication."
        }, 
        "brief_title": "Communication by Brain - Computer Interface in Amyotrophic Lateral Sclerosis:Feasibility Study", 
        "condition": "Amyotrophic Lateral Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Sclerosis", 
                "Motor Neuron Disease"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age >= 18\n\n          -  have a diagnosis of ALS suspected, possible, probable with EMG\n\n          -  be able to follow the study process and to comply with the schedule of visits upon\n             entry into the study\n\n          -  understand the purpose of the study\n\n          -  expressing P300 wave in the conditions of the study\n\n        Exclusion Criteria:\n\n          -  have a mental illness or clinical dementia defined clinically significant may hinder\n             the patient's ability to follow the procedures of the study\n\n          -  have a significant history of photosensitive epilepsy\n\n          -  have a history of allergy to the gel used for the electrodes\n\n          -  Major protected by law (guardianship, curators)\n\n          -  have uncorrectable visual disorders\n\n          -  not being able to maintain a sitting position and focus on a computer screen for more\n             than 30 min."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 9, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01897818", 
            "org_study_id": "12-PP-16"
        }, 
        "intervention": {
            "arm_group_label": "ALS patients", 
            "intervention_name": "communication system P300 Speller", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 9, 2013", 
        "location": {
            "contact": {
                "email": "desnuelle.c@chu-nice.fr", 
                "last_name": "Claude DESNUELLE, Pr"
            }, 
            "facility": {
                "address": {
                    "city": "Nice", 
                    "country": "France", 
                    "zip": "06202"
                }, 
                "name": "H\u00f4pital de l'Archet I"
            }, 
            "investigator": {
                "last_name": "Claude DESNUELLE, Pr", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "desnuelle.c@chu-nice.fr", 
            "last_name": "Claude DESNUELLE, Pr"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "the full achievement of \"copy spelling\" and \"free spelling\" tests session 1", 
                "safety_issue": "No", 
                "time_frame": "14 days after inclusion"
            }, 
            {
                "measure": "the full achievement of \"copy spelling\" and \"free spelling\" tests session 2", 
                "safety_issue": "No", 
                "time_frame": "28 days after inclusion"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01897818"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire de Nice", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire de Nice", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}